CSF-enriched antibodies do not share specificities among MS patients

Abstract

The specificity of the oligoclonal immunoglobulins found in MS CSF is unknown. We have previously shown that random peptide libraries displayed on phage can be used to identify specific ligands for CSF antibodies. Here we describe the use of this tool in the attempt to identify MS-specific CSF-enriched antibody reactivities with potential pathogenic, diagnostic or prognostic value. Applying different experimental strategies, several ligands reacting with CSF-enriched antibodies were identified. When tested against a panel of 55 MS patients, none of the ligands found were recognized by antibodies shared by any two patients. We used the selected peptides to demonstrate the stability in time of CSF-enriched antibodies notwithstanding disease progression.

Keywords

multiple sclerosis CSF oligoclonal bands phage library

Get full access to this article

View all access options for this article.

References

Vartdal F , Vandvik B , Norrby E. (1980) Viral and bacterial antibody responses in multiple sclersosis . Ann Neurol 1: 248-255 .

Rostrom B et al. (1981) Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis . Ann Neurol 9: 569-574 .

Cruz M et al. (1987) Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis . Neurology 37: 1515-1519 .

Cortese R et al. (1994) Epitope discovery with peptide libraries displayed on phage . TIBTECH 12: 262-267 .

Folgori A et al. (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera . EMBO J 13: 2236-2243 .

Cortese R et al. (1996) Selection of biologically active peptides by phage display of random peptide libraries . Curr Opin Biotechnol 7: 616-621 .

Cortese I et al. (1996) Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries . Proc Natl Acad Sci USA 93: 11063-11067 .

Cortese I et al. (1997) Identification of peptides binding to IgG in the CSF of multiple sclerosis patients . Multiple Sclerosis in press.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

10.

Felici F et al. (1991) Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector . J Mol Biol 222: 301-310 .

11.

Dente L et al. (1994) Monoclonal antibodies that recognise filamentous phage: tools for phage display technology . Gene 148: 7-13 .

12.

Tafi R et al. (1997) Identification of HCV core mimotopes: improved methods for the selection and use of disease-related phage-displayed peptides . Biol Chem 378: 495-502 .

13.

Olssen JE , Link H. (1973) Immunoglobulin abnormalities in multiple sclerosis . Arch Neurol 28: 392-399 .

14.

Hershey LA , Trotter JL. (1980) The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation . Ann Neurol 8: 426-434

15.

Ebers GC. (1985) Oligoclonal banding in MS . Ann NY Acad Sci 436: 206-212 .

16.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

17.

Williams KC , Ulvestad E , Hickey WF. (1994) Immunology of Multiple Sclerosis . Clinical Neuroscience 2: 229-245 .

18.

Storch M , Lassmann H. (1997) Pathology and pathogenesis of demyelinating diseases . Curr Opin Neurol 10: 186-192 .